cbdMD (YCBD) Retained Earnings (2016 - 2025)
cbdMD (YCBD) reported Retained Earnings of $188.8 million for Q4 2025, up 203.12% on a YoY basis from $62.3 million in Q4 2024, and up 1.13% sequentially from $186.7 million in Q3 2025.
cbdMD (YCBD) Retained Earnings (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Retained Earnings data on file, last reported at $188.8 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 203.12% year-over-year to $188.8 million; the trailing twelve-month figure through Dec 2025 stood at $188.8 million (up 203.12% YoY), and the FY2025 full-year result was $186.7 million, up 2596436.63% from the prior year.
- Retained Earnings rose to $188.8 million in Q4 2025, from $186.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $188.8 million in Q4 2025 to a low of -$183.1 million in Q4 2024.
- A 5-year average of $22.9 million and a median of -$6000.0 in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 199.82% in 2024 and surged 2596436.63% in 2025, its largest moves.
- Tracing YCBD's Retained Earnings over 5 years: stood at $177.8 million in 2021, then increased by 0.6% to $178.9 million in 2022, then climbed by 2.51% to $183.4 million in 2023, then sank by 199.82% to -$183.1 million in 2024, then soared by 203.12% to $188.8 million in 2025.
- Business Quant data shows YCBD's Retained Earnings at $188.8 million in Q4 2025, $186.7 million in Q3 2025, and -$179.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 188.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 188.76 Mn |
| Sep 30, 2025 | 186.65 Mn |
| Jun 30, 2025 | -179.10 Mn |
| Dec 31, 2024 | -183.05 Mn |
| Sep 30, 2024 | -7,189.00 |
| Jun 30, 2024 | -180.91 Mn |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 183.39 Mn |
| Sep 30, 2023 | -174.36 Mn |
| Jun 30, 2023 | -157.49 Mn |
| Mar 31, 2023 | -154.72 Mn |
| Dec 31, 2022 | 178.91 Mn |
| Sep 30, 2022 | 178.84 Mn |
| Jun 30, 2022 | 178.33 Mn |
| Mar 31, 2022 | 179.12 Mn |
| Dec 31, 2021 | 177.84 Mn |
| Sep 30, 2021 | -73.34 Mn |
| Jun 30, 2021 | -68.98 Mn |
| Mar 31, 2021 | 155.78 Mn |
| Dec 31, 2020 | 142.55 Mn |